Insider trades
Jason V. Coloma, CEO of Maze Therapeutics MAZE, has filed 0 purchases and 12 sales on the open market. Over the past 12 months that comes to a net sale of $2.7M. The latest trade was on 10/01.
Jason V. Coloma
CEO
- Company
- Maze Therapeutics MAZE
- First filing
- 25/09/24
- Trades
- 15 trades
- Buys / sales
- 0 / 12
- 12-month net buying
- −$2.7M
- Last trade
- 10/01
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
MAZE | Open-market sale10b5-1 plan | 10/01 | 10/02 | 34,501 sh2 trades | $27.02avg. | $932,259.56 | −15.3% |
MAZE | Open-market sale10b5-1 plan | 06/22–06/23 | 06/24 | 27,858 sh3 trades | $26.04avg. | $725,501.25 | −8.0% |
MAZE | Open-market sale10b5-1 plan | 06/01 | 06/03 | 6,643 sh2 trades | $26.20avg. | $174,068.72 | −19.2% |
MAZE | Open-market sale10b5-1 plan | 05/22–05/26 | 05/27 | 32,564 sh3 trades | $26.02avg. | $847,175.64 | −8.5% |
MAZE | Open-market sale10b5-1 plan | 05/15 | 05/18 | 1,938 sh2 trades | $26.00avg. | $50,388 | −5.9% |